Literature DB >> 23754285

ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.

Jacob Lund1, Ole H Olsen2, Esben S Sørensen3, Henning R Stennicke2, Helle H Petersen2, Michael T Overgaard4.   

Abstract

ADAMDEC1 (Decysin-1) is a putative ADAM (a disintegrin and metalloprotease)-like metalloprotease with an unknown physiological role, selectively expressed in mature dendritic cells and macrophages. When compared with other members of the ADAM family, ADAMDEC1 displays some unusual features. It lacks the auxiliary cysteine-rich, EGF, and transmembrane domains, as well as the cytoplasmic tail. The active site of ADAMDEC1 is unique by being the only mammalian ADAM protease with a non-histidine zinc ligand, having an aspartic acid residue instead. Here we demonstrate that ADAMDEC1, despite these unique features, functions as an active metalloprotease. Thus, ADAMDEC1 is secreted as a mature, glycosylated, and proteolytically active metalloprotease, capable of cleaving macromolecular substrates. In the recombinant form, three of the four potential N-linked glycosylation sites are modified by carbohydrate attachment. Substitution of basic residues at the predicted proprotein convertase cleavage site blocks proprotein processing, revealing both specific ADAMDEC1-dependent and specific ADAMDEC1-independent cleavage of the prodomain. The pro-form of ADAMDEC1 does not have proteolytic activity, demonstrating that the prodomain of ADAMDEC1, like in other members of the ADAM family, confers catalytic latency. Interestingly, the proteolytic activity of mature ADAMDEC1 can be significantly enhanced when a canonical ADAM active site with three zinc-coordinating histidine residues is introduced.

Entities:  

Keywords:  ADAM ADAMTS; Metalloprotease; Metzincin; Post-translational Modification; Protein Evolution; Protein Expression

Mesh:

Substances:

Year:  2013        PMID: 23754285      PMCID: PMC3774404          DOI: 10.1074/jbc.M113.474536

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Function and mechanism of zinc metalloenzymes.

Authors:  K A McCall; C Huang; C A Fierke
Journal:  J Nutr       Date:  2000-05       Impact factor: 4.798

2.  The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion.

Authors:  Uwe Schlomann; Dirk Wildeboer; Ailsa Webster; Olga Antropova; Dagmar Zeuschner; C Graham Knight; Andrew J P Docherty; Marc Lambert; Lisa Skelton; Harald Jockusch; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

Review 3.  Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure.

Authors:  Theo Klein; Rainer Bischoff
Journal:  J Proteome Res       Date:  2010-10-14       Impact factor: 4.466

4.  Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.

Authors:  Peter W Janes; Nayanendu Saha; William A Barton; Momchil V Kolev; Sabine H Wimmer-Kleikamp; Eva Nievergall; Carl P Blobel; Juha-Pekka Himanen; Martin Lackmann; Dimitar B Nikolov
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

5.  Crystallographic study of the binding of dipeptide inhibitors to thermolysin: implications for the mechanism of catalysis.

Authors:  W R Kester; B W Matthews
Journal:  Biochemistry       Date:  1977-05-31       Impact factor: 3.162

6.  Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.

Authors:  P Reddy; J L Slack; R Davis; D P Cerretti; C J Kozlosky; R A Blanton; D Shows; J J Peschon; R A Black
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

7.  N-Glycans of ADAMTS13 modulate its secretion and von Willebrand factor cleaving activity.

Authors:  Wenhua Zhou; Han-Mou Tsai
Journal:  Blood       Date:  2008-11-03       Impact factor: 22.113

8.  Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation.

Authors:  Kristina Endres; Andreas Anders; Elzbieta Kojro; Sandra Gilbert; Falk Fahrenholz; Rolf Postina
Journal:  Eur J Biochem       Date:  2003-06

9.  Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity.

Authors:  M Roghani; J D Becherer; M L Moss; R E Atherton; H Erdjument-Bromage; J Arribas; R K Blackburn; G Weskamp; P Tempst; C P Blobel
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

10.  Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.

Authors:  Donia P Macartney-Coxson; Kylie A Hood; Hong-jun Shi; Teresa Ward; Anna Wiles; Rosemary O'Connor; David A Hall; Rod A Lea; Janice A Royds; Richard S Stubbs; Serena Rooker
Journal:  BMC Cancer       Date:  2008-07-01       Impact factor: 4.430

View more
  13 in total

1.  Evidence for restricted reactivity of ADAMDEC1 with protein substrates and endogenous inhibitors.

Authors:  Jacob Lund; Linda Troeberg; Henrik Kjeldal; Ole H Olsen; Hideaki Nagase; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

Review 2.  Architecture and function of metallopeptidase catalytic domains.

Authors:  Núria Cerdà-Costa; Francesc Xavier Gomis-Rüth
Journal:  Protein Sci       Date:  2014-02       Impact factor: 6.725

3.  Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.

Authors:  Jacob Lund; Anne Mette Elimar Bitsch; Morten Grønbech Rasch; Mari Enoksson; Linda Troeberg; Hideaki Nagase; Mette Loftager; Michael Toft Overgaard; Helle Heibroch Petersen
Journal:  MAbs       Date:  2017-11-29       Impact factor: 5.857

4.  ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells.

Authors:  Ana Jimenez-Pascual; James S Hale; Anja Kordowski; Jamie Pugh; Daniel J Silver; Defne Bayik; Gustavo Roversi; Tyler J Alban; Shilpa Rao; Rui Chen; Thomas M McIntyre; Giorgio Colombo; Giulia Taraboletti; Karl O Holmberg; Karin Forsberg-Nilsson; Justin D Lathia; Florian A Siebzehnrubl
Journal:  Cancer Discov       Date:  2019-08-21       Impact factor: 39.397

5.  The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF.

Authors:  Rui Chen; Ge Jin; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2017-04-28       Impact factor: 5.157

6.  ADAM-like Decysin-1 (ADAMDEC1) is a positive regulator of Epithelial Defense Against Cancer (EDAC) that promotes apical extrusion of RasV12-transformed cells.

Authors:  Yuta Yako; Takashi Hayashi; Yasuto Takeuchi; Kojiro Ishibashi; Nobuhiro Kasai; Nanami Sato; Keisuke Kuromiya; Susumu Ishikawa; Yasuyuki Fujita
Journal:  Sci Rep       Date:  2018-06-25       Impact factor: 4.379

7.  MCSF drives regulatory DC development in stromal co-cultures supporting hematopoiesis.

Authors:  Sawang Petvises; Pravin Periasamy; Helen C O'Neill
Journal:  BMC Immunol       Date:  2018-06-26       Impact factor: 3.615

8.  Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel.

Authors:  Seong Beom Ahn; Samridhi Sharma; Abidali Mohamedali; Sadia Mahboob; William J Redmond; Dana Pascovici; Jemma X Wu; Thiri Zaw; Subash Adhikari; Vineet Vaibhav; Edouard C Nice; Mark S Baker
Journal:  Clin Proteomics       Date:  2019-08-28       Impact factor: 3.988

9.  Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing.

Authors:  Guadalupe J Jasso; Alok Jaiswal; Mukund Varma; Tyler Laszewski; Angelo Grauel; Abdifatah Omar; Nilsa Silva; Glenn Dranoff; Jeffrey A Porter; Keith Mansfield; Viviana Cremasco; Aviv Regev; Ramnik J Xavier; Daniel B Graham
Journal:  PLoS Biol       Date:  2022-01-27       Impact factor: 8.029

10.  Critical Role of the Disintegrin Metalloprotease ADAM-like Decysin-1 [ADAMDEC1] for Intestinal Immunity and Inflammation.

Authors:  Nuala R O'Shea; Thean S Chew; Jenny Dunne; Rebecca Marnane; Bahman Nedjat-Shokouhi; Philip J Smith; Stuart L Bloom; Andrew M Smith; Anthony W Segal
Journal:  J Crohns Colitis       Date:  2016-05-25       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.